Brief: Oncolytics Biotech® Reports First Quarter 2022 Financial Results
05/05/2022 21:03
May 5 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT OPERATIONAL HIGHLIGHTS
* Q1 LOSS PER SHARE C$0.12
* $39.5 MILLION IN CASH AND CASH EQUIVALENTS EXPECTED TO
PROVIDE
RUNWAY THROUGH KEY CATALYSTS AND INTO 2023
* Q1 EARNINGS PER SHARE VIEW C$-0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWltyw4a
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer